IOVS AJP: Endocrinology and Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, Y.
Right arrow Articles by Kapp, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, Y.
Right arrow Articles by Kapp, J. A.
(Investigative Ophthalmology and Visual Science. 2002;43:3473-3479.)
© 2002 by The Association for Research in Vision and Ophthalmology, Inc.

{gamma}{delta} T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses

Yijun Xu1,2 and Judith A. Kapp1

1 From the Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.

PURPOSE. Delivery of antigen to the anterior chamber (AC) of the eye induces a systemic form of tolerance, referred to as anterior chamber-associated immune deviation (ACAID). ACAID is characterized by decreases in delayed-type hypersensitivity responses and complement-fixing antibodies on subsequent challenge with an immunogenic form of the antigen. The current study was designed to test whether priming of antigen-specific CD8+ cytotoxic T-lymphocytes (CTLs) are inhibited by injection of soluble antigen into the AC and whether {gamma}{delta} T cells play a role in the inhibition of such responses.

METHODS. Antigen was administered through the AC to normal {gamma}{delta} T-cell-deficient or reconstituted {gamma}{delta} T-cell-deficient mice. Seven days after the AC injection, the mice were primed with antigen in adjuvant and 10 days later, their spleen cells were cultured for 5 to 7 days and the CTL responses measured.

RESULTS. CTL responses were inhibited by antigen delivered through the AC in normal but not {gamma}{delta} T-cell-deficient mice. Tolerance was reconstituted in {delta}-chain knockout mice by the adoptive transfer of {gamma}{delta} T cells from normal mice. Moreover, spleen cells and splenic {gamma}{delta}+ T cells, but not {gamma}{delta}- T cells, from mice injected with antigen through the AC inhibited development of CTL responses when cultured together with primed effector T cells.

CONCLUSIONS. These data show, for the first time, that administration of soluble antigen in the AC inhibits development of CD8+ cytotoxic T-cell responses and that {gamma}{delta} T cells play a critical role in inhibition of CTL responses.




This article has been cited by other articles:


Home page
IOVSHome page
R. L. O'Brien, M. A. Taylor, J. Hartley, T. Nuhsbaum, S. Dugan, K. Lahmers, M. K. Aydintug, J. M. Wands, C. L. Roark, and W. K. Born
Protective Role of {gamma}{delta} T Cells in Spontaneous Ocular Inflammation
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3266 - 3274.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Cui, H. Shao, C. Lan, H. Nian, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun
Major Role of {gamma}{delta} T Cells in the Generation of IL-17+ Uveitogenic T Cells
J. Immunol., July 1, 2009; 183(1): 560 - 567.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
S. Chattopadhyay, J. O'Rourke, and R. E. Cone
Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells
Int. Immunol., April 1, 2008; 20(4): 509 - 516.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Brouard, E. Mansfield, C. Braud, L. Li, M. Giral, S.-c. Hsieh, D. Baeten, M. Zhang, J. Ashton-Chess, C. Braudeau, et al.
Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance
PNAS, September 25, 2007; 104(39): 15448 - 15453.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. M. Ashour and J. Y. Niederkorn
{gamma}{delta} T Cells Promote Anterior Chamber-Associated Immune Deviation and Immune Privilege through Their Production of IL-10
J. Immunol., December 15, 2006; 177(12): 8331 - 8337.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. McKenna and J. A. Kapp
Accumulation of Immunosuppressive CD11b+ Myeloid Cells Correlates with the Failure to Prevent Tumor Growth in the Anterior Chamber of the Eye
J. Immunol., August 1, 2006; 177(3): 1599 - 1608.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. E. Faunce, A. Terajewicz, and J. Stein-Streilein
Cutting Edge: In Vitro-Generated Tolerogenic APC Induce CD8+ T Regulatory Cells That Can Suppress Ongoing Experimental Autoimmune Encephalomyelitis
J. Immunol., February 15, 2004; 172(4): 1991 - 1995.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. E. Skelsey, E. Mayhew, and J. Y. Niederkorn
Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5242 - 5251.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Association for Research in Vision and Ophthalmology